Resyca, a leader in soft mist-based drug delivery with its next-generation soft mist inhalers and soft nasal sprays, announces the appointment of Deborah Jones, Ph.D., as chief executive officer, ...

WASHINGTON (AP) — Makers of dietary supplements are pushing the Food and Drug Administration to expand the types of ingredients they can put in their products, a change that could open the door to ...

Globally, 262 million patients are diagnosed with asthma as of 2019, while in India, the asthma rate is at 2,241 per 100,000. These figures, according to the World Population Review, are significantly ...

RANCHO CUCAMONGA, CA / ACCESS Newswire / April 6, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") announced today that Bill Peters, CFO, Tony Marrs, EVP of ...

The Hershey Company will abandon its use of substitute ingredients in Reese's-branded candies and other products next year, addressing backlash that mounted when the grandson of founder H.B. Reese ...

Shares of pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) jumped 3.9% in the afternoon session after the stock's positive momentum continued as the company reported impressive financial ...

You may have noticed a haze over the Chattanooga area Thursday due to the Code Orange Alert caused by nearby wildfires. Poor air quality can be harmful for certain groups, like those with lung disease ...

Sarah is an experienced writer and editor enthusiastic about helping readers live their healthiest and happiest lives. Before joining Forbes Health, Sarah worked as a ...

The Food and Drug Administration is pulling Primatene Mist from the market Jan. 1. The ban is the result of the Montreal Protocol treaty, which prohibits the sale of certain products containing ...

Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and ...